ReviewClinical and experimental immunology2008
Clinical immunology review series: an approach to the patient with anaphylaxis.
Review in Clinical and experimental immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 27 citations in OpenAlex.
- Ketorolac-induced anaphylaxis following oral administration: a case series.Annals of medicine and surgery (2012) · 2023Article
- Allergy in Irish adults: a survey of referrals and outcomes at a major centre.Irish journal of medical science · 2015Article
- In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency.Clinical and experimental immunology · 2013Article
- An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease.Advances in experimental medicine and biology · 2011Review
- Anaphylactoid reaction after injection of ketorolac in a loading dose for patient-controlled analgesia -A case report-.Korean journal of anesthesiology · 2010Article
- Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice.The Journal of clinical investigation · 2010Article
- Clinical Immunology Review Series: An approach to the patient with allergy in childhood.Clinical and experimental immunology · 2009Review
- An approach to the patient with urticaria.Clinical and experimental immunology · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaphylaxis is a severe, life-threatening, generalized or systemic hypersensitivity reaction. While there is agreement as to this definition of anaphylaxis, the clinical presentation is often variable and it is not uncommon for there to be debate after the event as to whether anaphylaxis had actually occurred. The management of anaphylaxis falls into two distinct phases: (1) emergency treatment and resuscitation of a patient with acute anaphylaxis and (2) the search for a cause for the event and the formulation of a plan to prevent and treat possible further episodes of anaphylaxis. Both aspects are important in preventing death from anaphylaxis and are covered in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.